ClinicalTrials.Veeva

Menu

Therapeutic Effects of Arch Support Insoles on Children

T

Taipei Medical University

Status

Completed

Conditions

Normal Development

Treatments

Device: MEI BIN insoles

Study type

Interventional

Funder types

Other

Identifiers

NCT03198299
SKH-8302-105-DR-24

Details and patient eligibility

About

Using double blind, randomized controlled design to study the short-term therapeutic effects of customized arch support insoles on children

Full description

A total of 45 children were enrolled. The children were randomized into two groups, including the study group (insoles group) and the control group (without insoles group).

All participants in the insoles group were evaluated at baseline, that was before the customized arch-support insoles were prescribed. All the evaluations, including functional performance, physical function, and quality of life, were re-evaluated up to 12 weeks after the insoles wearing in the study group (insoles group).

The control group were evaluated at baseline and up to 12 weeks.

Enrollment

45 patients

Sex

All

Ages

3 to 10 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • children with age 3 to 10 can walk independently for 15 meters can follow up for 12 weeks

Exclusion criteria

  • age less than 3 years or older than 10 years children with developmental delays children with pathological flat feet

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

45 participants in 2 patient groups

study group: MEI BIN insoles
Active Comparator group
Description:
Study group: participants in the study group were prescribed with customized insoles (MEI BIN insoles) to keep the subtalar joint in neutral position, for 12 weeks.
Treatment:
Device: MEI BIN insoles
control group: without MEI BIN insoles
No Intervention group
Description:
Control group: participants in the control group were not prescribed with customized insoles (MEI BIN insoles) to keep the subtalar joint in neutral position, for 12 weeks.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems